about us

About us

Kedrion Biopharma is an international biopharmaceutical company based in Italy that collects and fractionates plasma to produce and distribute worldwide plasma-derived products for the prevention and treatment of rare and debilitating diseases and conditions such as Hemophilia, Primary Immunodeficiencies and Rh sensitization.

Kedrion operates in Autria through its subsidiary Kedrion Biopharma GmbH – Zweigniederlassung Österreich specialized in marketing, sales and distribution of plasma derivatives medicines.

Read more


As a result of its solid and successful experience as partner with the Italian Health System, its significant expansion into international operations and a fundamental commitment to research and development, Kedrion’s line of plasma-derived products is broad and diverse.

With treatments for many rare and debilitating diseases and conditions from hemolytic disease in newborns to immune deficiencies to hemophilia, Kedrion offers a wide and expanding array of treatments and therapies.

Below the list of Kedrion products distributed in Austria (updated May 2023).

Contact us

Thank you for your interest in Kedrion. You can contact us directly by submitting a message form. Please follow the links below according to your interests or subject of inquiry.

For commercial information

EN: Kedrion In The World
Policy *
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For medical information regarding our products

EN: Medical scientific information
Qualification *
If medical, please indicate your specialty
If patient, please report the contact details of the doctor or the treating center
Please do not use this field to report adverse events (side effects) or product complaints: In the event of a complaint, please contact the Quality Assurance department. In case of adverse reactions please contact the Pharmacovigilance.
Privacy Policy *
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

To report an adverse reaction to one of our products.
Contact the Competent Authority’s Pharmacovigilance Office.
If you wish to directly notify Kedrion about a suspected adverse reaction related to our drugs, please fill in the form below:

EN: Pharmacovigilance
Qualification *
Gender (M/F)
Has the adverse event stopped?
How bad was the adverse event?
How is the adverse event now?
In processing your personal data, Kedrion will fully comply with internationally recognized standards of data protection. In doing so, Kedrion ensures compliance of its staff with strict standards of security and confidentiality.
Privacy *
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


For Orders:
Fax: +43 1 80 104-2469
E-Mail: [email protected]

For sales inquiries:
Ruth Langner,
Key Account Manager, Österreich
Tel.: +43 676 331 62 11
E-Mail: [email protected]

Aleksandar Marinkovic
Sales Manager, Austria, gewerberechtlicher Geschäftsführer
Tel.: +43 664 88 60 30 91
E-Mail: [email protected]